Welcome to LookChem.com Sign In|Join Free

CAS

  • or

10443-86-4

Post Buying Request

10443-86-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

10443-86-4 Usage

Class

Organic diselenides (compounds containing a selenide group bonded to two organic moieties)

Type

Pyrimidine derivative (heterocyclic ring with a diselenide group at the 2 and 4 positions)

Rarity

Relatively rare and unusual compound

Potential applications

Organic synthesis, coordination chemistry, antioxidant, and medicinal properties (requires further research for full understanding of potential uses and effects)

Check Digit Verification of cas no

The CAS Registry Mumber 10443-86-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,4,4 and 3 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 10443-86:
(7*1)+(6*0)+(5*4)+(4*4)+(3*3)+(2*8)+(1*6)=74
74 % 10 = 4
So 10443-86-4 is a valid CAS Registry Number.

10443-86-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,4-bis(λ<sup>1</sup>-selanyl)pyrimidine

1.2 Other means of identification

Product number -
Other names 1H-pyrimidine-2,4-diselone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10443-86-4 SDS

10443-86-4Upstream product

10443-86-4Downstream Products

10443-86-4Relevant articles and documents

Chalcogen containing heterocyclic scaffolds: New hybrids with antitumoral activity

Alcolea, Verónica,Plano, Daniel,Encío, Ignacio,Palop, Juan Antonio,Sharma, Arun K.,Sanmartín, Carmen

, p. 407 - 418 (2016/08/04)

In this work, 27 novel hybrid derivatives containing diverse substituents with chalcogen atoms (selenium or sulfur) and several active heterocyclic scaffolds have been synthesized. Compounds were tested against two human cancer cells lines (MCF7 and PC-3) and a normal human mammary epithelial cell line (184B5) in order to determine their activity and selectivity against malignant cells. Ten compounds showed GI50values below 10?μM in at least one of the cancer cell lines and six of them exhibited a selectivity index higher than 9. In general, selenium-containing compounds were more active than their corresponding sulfur analogs but we found some thiocyanate derivatives with comparable or higher activity and selectivity. Among the different substituents, the seleno- and thio-cyanate groups showed the most promising results. On the basis of their potent activity and high selectivity index, compounds 7e and 8f (containing a thiocyanate and a selenocyanate group, respectively) were selected for further biological evaluation. Both the compounds induced caspase-dependent cell death and cell cycle arrest in G2/M phase. In addition, these compounds do not violate any of the Lipinski's Rule of Five and thus possess good potential to become drugs, compound 7e being particularly promising.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 10443-86-4